2nd Quarter - Report
THE STRATEGY GROUP, INC. for PHRMA
Client
Income
$10,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
340B Pharmacy Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN VIRGINIA KELLY | — |
| DAVID NEWMAN | — |
Copyright/Patent/Trademark CPT
Patent Reform, HR 9 The Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN VIRGINIA KELLY | — |
| SUSAN TRACY | — |
Medicare/Medicaid MMM
Medicare Part D and the Independent Payment Advisory Board
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN VIRGINIA KELLY | — |
| DAVID NEWMAN | — |
| SUSAN TRACY | — |
Medical/Disease Research/Clinical Labs MED
NIH Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN VIRGINIA KELLY | — |
| DAVID NEWMAN | — |
| SUSAN TRACY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.